Breelyn A. Wilky

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial

Breelyn A. Wilky, Matteo Trucco, Ty K. Subhawong et al. · The Lancet Oncology · 2019 · 385 citations

Medicine, Oncology, Pharmacology +11

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak et al. · The Lancet · 2024 · 263 citations · Full text

Medicine, Oncology, Chemotherapy +13

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor et al. · New England Journal of Medicine · 2023 · 242 citations · Full text

Medicine, Oncology, Pharmacology +13

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Silvia Stacchiotti, Anna Maria Frezza, Jean‐Yves Blay et al. · Cancer · 2021 · 227 citations · Full text

Medicine, Oncology, Pathology +14

Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Vaia Florou, Andrew E. Rosenberg, Eric Wieder et al. · Journal for ImmunoTherapy of Cancer · 2019 · 181 citations · Full text

Medicine, Immunology, Oncology +17